尼扎替丁

Name: 尼扎替丁
Brand: 济南圣和化工有限公司

CAS 76963-41-2C12H21N5O2S2MW 331.5

济南圣和化工主营供应尼扎替丁（CAS 76963-41-2），归类于有机化学品，分子式 C12H21N5O2S2，分子量 331.5。我们面向国内化工贸易与生产企业提供稳定的现货供应，报价响应快，支持对公转账并可开具增值税发票。

产品概览

CAS号	76963-41-2
分子式	C12H21N5O2S2
分子量	331.5
熔点	130-132 °C
LogP	1.1
纯度	按批次COA提供(不公开发布)
包装	按订单/批次确认(不公开发布)
应用领域	有机化学品
类别	有机化学品

应用领域

有机化学品

尼扎替丁主要应用于有机化学品。具体使用工况下的添加量与规格要求，欢迎与技术团队沟通确认。

包装与储存

包装规格按订单/批次确认(不公开发布)

纯度规格按批次COA提供(不公开发布)

储存条件密封、阴凉干燥处保存

运输常规化工运输

样品可协商提供

交期现货/按订单安排

采购提示：本产品按按订单/批次确认(不公开发布)起订发货，收到货物后请先核对包装完好性再行入库。储存条件为阴凉干燥、密封保存；如需 MSDS 或运输说明，可在询价时一并索取。

质量与文件

每批产品随货提供 COA（分析证书）；可按需提供 MSDS/技术数据表及第三方检测报告。纯度与包装以批次 COA 及订单确认为准。

关于供应商

选择济南圣和化工有限公司的理由：产品信息透明（含 CAS、分子式、理化参数）、报价响应快（一个工作日内）、单证齐全（COA/MSS/质检资料按需提供）、支持批量与长期协议供货。如需尼扎替丁以外的配套原料，也欢迎一并列出需求清单。

常见问题

尼扎替丁的 CAS 号是多少？

尼扎替丁的 CAS 号为 76963-41-2。

该产品的纯度和包装规格是什么？

常规纯度规格为按批次COA提供(不公开发布)，包装为按订单/批次确认(不公开发布)，随货提供 COA。

尼扎替丁有什么用途？

主要应用于有机化学品。

如何购买或获取报价？

请发送邮件至 info@591daili.com 或通过 WhatsApp 联系，注明产品名称、CAS 号与需求数量，一个工作日内回复报价。供应商：济南圣和化工有限公司。

PubChem 公开数据

Description

Nizatidine · CAS 76963-41-2 · C12H21N5O2S2. UNII P41PML4GHR. Melting Point: 130-132 °C; Solubility: 10-33mg/mL; LogP: 1.1.

Identification

CAS Registry Number	76963-41-2
PubChem CID	4513
Molecular formula	C12H21N5O2S2
IUPAC name	1-N'-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine
UNII (FDA)	P41PML4GHR

Computed Descriptors

Molecular Weight	331.5
XLogP3	1.6
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	9
Exact Mass	331.11366728
Monoisotopic Mass	331.11366728
Topological Polar Surface Area	140
Heavy Atom Count	21
Formal Charge	0

Physical & Chemical Properties

Melting Point	130-132 °C
Solubility	10-33mg/mL
LogP	1.1

Physical description & handling notes

Crystals from ethanol-ethyl acetate
Off-white to buff crystalline solid
Mild, sulfur-like odor
Bitter
Soluble in water
178.1 Å² [M+Na]+ [CCS Type: DT; Buffer gas: N2; Ionization: ESI+; Dataset: TOXCAST; Source Identifier: DTXSID5023376]

GHS Hazard Classification

Reported hazard statements	H302 (97.6%)

H302 (97.6%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Documented Uses

RP Pioch, Eur Pat Appl 49618; Idem, US Pat 4,375547 (1982, 1983 both to Eli Lilly)
For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.
Nizatidine is a histamine type 2 receptor antagonist (H2 blocker) which is widely used for treatment of acid-peptic disease and heartburn. Nizatidine has been linked to rare instances of clinically apparent acute liver injury.
Breast Feeding; Lactation; Anti-Ulcer Agents; Histamine H2 Antagonists; Gastrointestinal Agents
Nizatidine (Class: Other Substances, Added Date: 01-2001)
Anti-Ulcer Agents; Histamine H2 Antagonists

Synonyms

Acinon; Nizatidina; Axid; Axid Ar; Nizatidinum; DTXSID5023376; P41PML4GHR; LY 139037; NSC-759289; 1,1-Ethenediamine, N-(2-(((2-((dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-; LY-139037; N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; N-(4-(6-Methylamino-7-nitro-2-thia-5-aza-6-hepten-1-yl)-2-thiazolylmethyl)-N,N-dimethylamin; CHEBI:7601; DTXCID403376; n-[2-[[[2-[(dimethylamino)methyl]-4-thiazolyl]methyl]thio]ethyl]-n'-methyl-2-nitro-1,1-ethenediamine

Frequently Asked Questions

What are the CAS number and molecular formula of Nizatidine?

CAS 76963-41-2; molecular formula C12H21N5O2S2; molecular weight — g/mol.

What other names is Nizatidine known by?

Acinon, Nizatidina, Axid, Axid Ar, Nizatidinum, DTXSID5023376.

Is Nizatidine classified as hazardous?

Hazard statements reported: H302.

What are the key physical properties of Nizatidine?

Melting Point: 130-132 °C; Solubility: 10-33mg/mL; LogP: 1.1.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.